Our Portfolio

CST Capital is currently pursueing several potential options for acquisition in the Mexican Pharmaceutical Industry.
The current target companies represent various dosage forms.
For more information about a potential investment into one ore more of these options, please contact us.
We will be able to disclose more information about investment options under a Confidentiality Agreement.
Investment targets are forecasted a a minimum IRR of 25% and can range up to 40%.
Typical duration of an investment until financial maturity is about 5-7 years.